– Data Showed LEQEMBI Slowed Clinical Decline by 1.75 Points on CDR-SB at Four Years Compared to the Natural History of Alzheimer’s Disease – 56% of Patients with Low Tau […]
TOKYO and CAMBRIDGE, Mass., July 31, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”)and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, CEO: Christopher […]
TOKYO and CAMBRIDGE, Mass., July 31, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito,“Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: […]
TOYOTA CITY, July 30, 2025 – (JCN Newswire via SeaPRwire.com) – Toyota Motor Corporation announces its sales, production, and export results for June 2025 as well as the cumulative total from […]
Santa Clara, CA, July 29, 2025, (ACN Newswire via SeaPRwire.com) – Meshy.ai, the world’s leading AI-powered 3D content generation platform, has launched the Meshy 5 Preview, offering early access to […]
TOKYO, July 30, 2025 – (JCN Newswire via SeaPRwire.com) – Sharp Corporation has reached an agreement with Mitsubishi Chemical Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Manabu Tsukimoto), the National Institute of […]
Mitsubishi Heavy Industries aims to integrate DCIM (Data Center Infrastructure Management) into its One-stop solutions portfolio to offer digital services to data centers The combination delivers a comprehensive view of […]
Osaka, Japan, July 29, 2025 – (JCN Newswire via SeaPRwire.com) – Osaka Prefecture has finalized the detailed program for the OSAKA JAPAN SDGs Forum to be held on Friday, September 5, […]
TOKYO, July 29, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that its in-house discovered tyrosine kinase inhibitor, “LENVIMA®” (generic […]
Olympus to take a significant equity stake in Swan EndoSurgical with a combined initial investment of at least $65 million. Swan EndoSurgical to develop an innovative endoluminal robotic system for […]
TOKYO, July 25, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has been included in the FTSE4Good Index Series […]
Over 100 attendees gathered at Suntec Singapore Convention & Exhibition Centre forONERHT Foundation’s 8th GAIL Forum 2025 Forum featured high-level discussions on a wide range of topics including green leadership,ESG […]
Kawasaki and Nagoya, Japan, July 24, 2025 – (JCN Newswire via SeaPRwire.com) – Fujitsu Limited and Nagoya University, a member of the Tokai National Higher Education and Research System (THERS), […]
TOKYO, Japan, July 24, 2025 – (JCN Newswire via SeaPRwire.com) – Honda Motor Co., Ltd. (Honda) today revealed some details of how it will support the World Athletics Championships Tokyo 25 […]
– Rationalization of domestic production technologies and strengthening of the system in Japan for manufacturing divertor outer vertical targets for ITER– Seeking to contribute to the ITER Project and provide […]
Showcasing a prototype LEO satellite communication terminal (*1) enabling high-speed, high-capacity communication in areas with limited cellular coverage TOKYO, July 23, 2025 – (JCN Newswire via SeaPRwire.com) – Sharp Corporation (herein […]
TOKYO, July 23, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and KYORIN Pharmaceutical Co., Ltd.(Headquarters: Chiyoda-ku, Tokyo, President and CEO: Yutaka Ogihara, […]
SAN DIEGO, July 23, 2025 – (JCN Newswire via SeaPRwire.com) – Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and […]
TOKYO, July 22, 2025 – (JCN Newswire via SeaPRwire.com) – Mitsubishi Motors Corporation (hereafter, Mitsubishi Motors) announced the termination of its engine business operation at Shenyang Aerospace Mitsubishi Motors Engine […]
Latest findings from Eisai’s robust Alzheimer’s disease (AD) pipeline include results from lecanemab longterm data, an immunoassay for measuring amyloid-B protofibrils in cerebrospinal fluid, and asubcutaneousl form of lecanemab for […]
